Clinical Trial Update: Clinical Study on the Safety and Efficacy of CD20/CD19 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin Lymphoma [NA]

View source ↗

Summary

A clinical study is evaluating the safety and efficacy of a CD20/CD19 cell injection for relapsed or refractory B-cell non-Hodgkin lymphoma, with the trial curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Or Refractory B-cell Non-hodgkin Lymphoma

Drugs mentioned

• CD20/CD19 cell injection

Snippet

Sponsor: Donghua Zhang | Conditions: R/R B-NHL, Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (R/R B-NHL) | NA | Status: NOT_YET_RECRUITING